ebook Munafa Stock Market Course + Intraday & FNO calls  

       

SPRO announcements Spero Therapeutics, Inc. announcements and dividends declared NASDAQ

Spero Therapeutics, Inc. Complete list of announcements declared & dividend announcements by Spero Therapeutics, Inc. SPRO

Spero Therapeutics, Inc. SPRO listed on NASDAQ and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Spero Therapeutics, Inc. SPRO

Spero Therapeutics (SPRO) Loses -9.32% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Spero Therapeutics (SPRO) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Announcement as on 16 December 2024

Spero Therapeutics Reports Phase 1 Results Show Significant Lung Uptake Of SPR719
(RTTNews) - Spero Therapeutics Inc. (SPRO) announced that phase 1 results indicated significant lung uptake of SPR719, with enhanced concentrations in epithelial lining fluid (ELF) and alveolar macrophages (AM). This is attributed to the fact that unbound
Announcement as on 02 October 2024

Spero Therapeutics stock plummets after biotech to cut 75% of its workforce
Shares of Spero Therapeutics Inc. plummeted 68.4% toward a record low in premarket trading Tuesday, after the Massachusetts-based biopharmaceutical company said it is cutting 75% of its workforce following its decision to immediately defer commercializati
Announcement as on 03 May 2022

Spero Therapeutics Says FDA Lifts Clinical Trial Hold On SPR720 - Quick Facts
(RTTNews) - Spero Therapeutics, Inc. (SPRO) announced Tuesday that the U.S. Food and Drug Administration (FDA) has lifted the clinical hold on the Phase 2 trial of SPR720, Spero's investigational oral product candidate being developed for nontuberculous my
Announcement as on 04 January 2022

Announcements by Spero Therapeutics, Inc. first page |

SPRO Spero Therapeutics, Inc. current price & indicator signals

Moving Averages for Spero Therapeutics, Inc.

  • 5Day Average: 2.3
  • 12Day Average: 2.31
  • 20Day Average: 2.35
  • 50Day Average: 2.32
  • 100Day Average: 2.19
  • 150Day Average: 2.18
  • 200Day Average: 1.81

SPRO Indicators & signals

Indicator MACD (12,26,9)

2.31, 2.33, -0
Indicator MACD is in negative zone

Indicator ADX (14)

0, 53.85, 53.85
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 45
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of SPRO Spero Therapeutics, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
10 Wed Dec 2025 2.33 2.31 to 2.39 0% 1.08 times
09 Tue Dec 2025 2.33 2.26 to 2.35 0.87% 1.13 times
08 Mon Dec 2025 2.31 2.27 to 2.36 2.21% 1.04 times
05 Fri Dec 2025 2.26 2.25 to 2.31 -0.88% 0.52 times
04 Thu Dec 2025 2.28 2.24 to 2.33 0% 0.78 times
03 Wed Dec 2025 2.28 2.18 to 2.29 3.64% 1.18 times
02 Tue Dec 2025 2.20 2.20 to 2.29 -3.08% 1.63 times
01 Mon Dec 2025 2.27 2.26 to 2.38 -5.42% 1.19 times
28 Fri Nov 2025 2.40 2.33 to 2.42 3% 0.44 times
26 Wed Nov 2025 2.33 2.28 to 2.38 -0.43% 1.17 times
25 Tue Nov 2025 2.34 2.30 to 2.37 -1.68% 0.92 times
24 Mon Nov 2025 2.38 2.33 to 2.40 3.03% 2.03 times

Videos related to: SPRO announcements Spero Therapeutics, Inc. announcements and dividends declared NASDAQ

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

SPRO announcements Spero Therapeutics, Inc. announcements and dividends declared NASDAQ

 

Back to top